CYANOTECH CORP

CYANOTECH CORP (ticker: CYAN) is an OTC-listed medicinal chemicals & botanical products company. DredgeCap's structured extraction of CYAN's SEC filings surfaces 12 active risk signals, including 9 late-filing signals, 2 delisting/deregistration signals, and 1 auditor-change signal. CYAN reported $12.80M in revenue and -$925K for the period ending 2025-09-30, with operating cash flow of -$220K. Cash and equivalents stood at $649K (down 16.8% year-over-year). Total assets of $24.03M exceed total liabilities of $15.96M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

CYAN Cash Runway

Months-of-runway analysis for CYAN, derived directly from SEC XBRL: latest cash and operating cash flow, monthly burn rate, runway under current conditions. Historical trend + verbatim citation panel ships in Phase 2.

Coming in Phase 2

The dedicated per-ticker cash-runway page will surface a 6-8 quarter trend with the underlying us-gaap:CashAndCashEquivalentsAtCarryingValue + us-gaap:NetCashProvidedByUsedInOperatingActivities citations alongside each data point. In the meantime, see the ranked cross-company view:

All companies ranked by months-of-runway →

Related on CYAN

Share-count dilution →

Dilution is the natural counterpart to runway burn.

Going-concern history →

Auditor + management language across filings.